Beta-elemonic acid is primarily studied for its potential in pharmacological applications. Research indicates it exhibits anti-inflammatory and anti-cancer properties, making it a candidate for therapeutic drug development. It has been explored for its ability to inhibit the growth of certain cancer cells, particularly in studies related to liver and lung cancer. Additionally, its anti-inflammatory effects are being investigated for use in treating chronic inflammatory diseases. The compound is also of interest in traditional medicine, where it is used for its purported healing and protective effects. Further studies are ongoing to fully understand its mechanisms and potential clinical applications. While preliminary research suggests possible applications in cosmetics for skin anti-inflammatory effects and in nutraceuticals, these uses are not yet established commercially.